PAPOTTI, BIANCA
 Distribuzione geografica
Continente #
AS - Asia 1.656
NA - Nord America 1.615
EU - Europa 1.000
SA - Sud America 241
AF - Africa 83
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.598
Nazione #
US - Stati Uniti d'America 1.561
SG - Singapore 576
IT - Italia 427
VN - Vietnam 330
CN - Cina 307
BR - Brasile 181
HK - Hong Kong 137
IE - Irlanda 92
DE - Germania 82
BD - Bangladesh 79
FR - Francia 71
ZA - Sudafrica 58
RU - Federazione Russa 53
IN - India 45
SE - Svezia 43
AT - Austria 42
NL - Olanda 40
GB - Regno Unito 35
JP - Giappone 30
AR - Argentina 27
KR - Corea 26
CA - Canada 23
ES - Italia 21
MX - Messico 20
TR - Turchia 20
FI - Finlandia 19
IQ - Iraq 18
ID - Indonesia 12
LU - Lussemburgo 12
PL - Polonia 11
LT - Lituania 10
PK - Pakistan 9
BE - Belgio 8
CO - Colombia 8
PH - Filippine 8
TH - Thailandia 7
CL - Cile 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
MA - Marocco 6
PY - Paraguay 6
UZ - Uzbekistan 6
IL - Israele 5
MY - Malesia 5
TW - Taiwan 5
AL - Albania 4
AZ - Azerbaigian 4
SA - Arabia Saudita 4
UA - Ucraina 4
CI - Costa d'Avorio 3
HU - Ungheria 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
PA - Panama 3
QA - Qatar 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
VE - Venezuela 3
DZ - Algeria 2
EG - Egitto 2
MD - Moldavia 2
NP - Nepal 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
TO - Tonga 1
UY - Uruguay 1
Totale 4.598
Città #
Singapore 333
Ashburn 254
Dallas 242
San Jose 199
Hong Kong 123
Parma 108
Santa Clara 101
Dublin 92
Ho Chi Minh City 92
Hanoi 82
Boardman 75
Beijing 63
Chandler 62
Hefei 54
Johannesburg 54
Chicago 52
Los Angeles 48
New York 44
Shanghai 39
Lauterbourg 32
Munich 29
Hillsboro 26
Vienna 26
Seoul 23
Tokyo 23
Council Bluffs 19
Milan 18
Frankfurt am Main 17
Marseille 17
São Paulo 17
Moscow 16
Bologna 15
Haiphong 14
Modena 13
Da Nang 12
Rome 12
Denver 11
Seattle 11
Atlanta 10
Bremen 10
Buffalo 10
Montreal 10
Nuremberg 10
Orem 10
Turku 10
Warsaw 10
Genoa 9
Helsinki 9
Istanbul 9
London 9
Phoenix 9
Poplar 9
San Francisco 9
Bengaluru 8
Brooklyn 8
Chennai 8
Mexico City 8
Toronto 8
Columbus 7
Formigine 7
Jakarta 7
Luxembourg 7
Piacenza 7
Princeton 7
Pune 7
Reggio Emilia 7
Ann Arbor 6
Dalmine 6
Graz 6
Guangzhou 6
Madrid 6
Mumbai 6
Poviglio 6
Verona 6
Wilmington 6
Baghdad 5
Biên Hòa 5
Brno 5
Castello Molina di Fiemme 5
Charleroi 5
Como 5
Hải Dương 5
Ninh Bình 5
Pittsburgh 5
Tashkent 5
Amsterdam 4
Ankara 4
Bangkok 4
Belo Horizonte 4
Canoas 4
Florence 4
Houston 4
Manchester 4
Memphis 4
Naples 4
New Delhi 4
Padua 4
Paris 4
Rio de Janeiro 4
Schwindegg 4
Totale 2.871
Nome #
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 283
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 249
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 201
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 171
Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum 168
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 167
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) GENETIC DELETION ATTENUATES AMYLOID-. PATHOLOGY, NEUROINFLAMMATION AND IMPROVES COGNITIVE FUNCTIONS IN AN ALZHEIMER'S DISEASE MOUSE MODEL 162
HDL cholesterol efflux capacity and cholesterol loading capacity in long-term fasting: Evidence from a prospective, single-arm interventional study in healthy individuals 159
Changes in serum cholesterol loading capacity are linked to coronary atherosclerosis progression in rheumatoid arthritis 158
Drug-drug interactions in polypharmacy patients: The impact of renal impairment 151
Serum cholesterol loading capacity on macrophages is regulated by seropositivity and C-reactive protein in rheumatoid arthritis patients 148
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 142
Dysfunctional high-density lipoproteins in type 2 diabetes mellitus: Molecular mechanisms and therapeutic implications 135
HDL Proteome and Alzheimer's Disease: Evidence of a Link. 130
A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus 124
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis 123
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer's Disease 118
Impact of dietary lipids on the reverse cholesterol transport: What we learned from animal studies 113
Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease 100
Hdl in covid-19 patients: Evidence from an italian cross-sectional study 100
Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis 99
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells 97
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity 96
“Investigating PCSK9 inhibition as potential strategy in Alzheimer’s disease” 93
In vitro evaluation of the immunomodulatory activity of the nutraceutical formulation AminoDefence 92
Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis 91
Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis 84
Bioactive Alkaloids from Nepalese Corydalis chaerophylla D.C. Acting on the Regulation of PCSK9 and LDL-R In Vitro 84
Gene Silencing of Angiopoietin-like 3 (ANGPTL3) Induced De Novo Lipogenesis and Lipid Accumulation in Huh7 Cell Line 82
Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism 81
"Effect of natural and synthetic PCSK9 inhibitors on Alzheimer’s disease-related parameters in human cerebral cell models" 55
Relationship Between Cholesterol Accumulation and Cellular Senescence in an In Vitro Model of Human Macrophages 53
Investigating PCSK9 as a therapeutic target in Alzheimer's disease: evidence from patient-derived astrocytes 53
In vitro and in vivo studies on novel PCSK9 inhibitors as pharmacological approach for the treatment of Alzheimer’s disease 51
Sirtuin1, not NAMPT, possesses anti-inflammatory effects in epicardial, pericardial and subcutaneous adipose tissue in patients with CHD 51
“PCSK9 inhibition as potential strategy to treat Alzheimer’s disease: in vitro and in vivo studies” 49
Relationship Between Cholesterol Accumulation and Cellular Senescence in an In Vitro Model of Vascular Cells 48
“Studi in vitro e in vivo per lo sviluppo di nuovi inibitori di PCSK9 come strategia terapeutica nella malattia di Alzheimer” 42
Relationship between Cholesterol Accumulation and Cellular Senescence in an In Vitro Model of Human Macrophages 41
RELATIONSHIP BETWEEN CHOLESTEROL ACCUMULATION AND CELLULAR SENESCENCE IN AN IN VITRO MODEL OF HUMAN MACROPHAGE: POTENTIAL PROTECTIVE EFFECTS OF RESVERATROL 39
“Probing the efficacy of natural and novel synthetic PCSK9 inhibitors in reducing neuroinlfammation, Aβ-induced neurotoxicity and modulating cholesterol uptake in human cerebral cell models” 36
Mechanisms, Mediators, and Pharmacological Approaches Targeting Brain Cholesterol Transport in Alzheimer's Disease 36
Sex and reproductive stage modify the effect of endogenous oestrogens on coronary atherosclerosis in rheumatoid arthritis 35
RELATIONSHIP BETWEEN CHOLESTEROL ACCUMULATION AND CELLULAR SENESCENCE IN AN IN VITRO MODEL OF HUMAN MACROPHAGE: POTENTIAL PROTECTIVE EFFECTS OF RESVERATROL 32
“Proprotein convertase subtilisin/kexin type 9 and plasma/cerebrospinal fluid lipids in patients with cognitive decline” 31
Optimization of 4‐Amino‐2‐Pyridone Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9: Integrating Structure–Activity and Structure–Metabolism Relationships 14
Influence of Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) on brain cholesterol metabolism and potential impact on Alzheimer's Disease pathogenesis 2
Totale 4.669
Categoria #
all - tutte 15.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/202247 0 0 7 2 3 9 7 5 0 0 0 14
2022/2023318 16 23 16 22 44 23 14 23 104 15 16 2
2023/2024367 27 27 14 14 13 42 38 35 22 14 32 89
2024/2025908 32 38 57 78 73 84 90 50 82 81 89 154
2025/20262.992 212 320 331 208 368 178 270 192 355 262 217 79
Totale 4.669